Latest Regulation News

Commonwealth Bank of Australia reported a 5% increase in statutory net profit after tax to $5.367 billion for the half year ended December 2025, supported by lending growth and improved credit quality despite margin pressures and higher expenses. The bank declared a fully franked interim dividend of $2.35 per share.

Orbminco Limited has issued 62.5 million shares to raise $1 million as part of a staged capital raising, with shareholder approval for the next tranche expected in March.

The Takeovers Panel has declared unacceptable circumstances in Identitii Limited's recent rights issue, ordering supplementary disclosure and a reopening of the offer to protect shareholder interests and market integrity.

EVE Health Group has officially launched Libbo™, an oral dissolving film for erectile dysfunction, alongside a new digital platform aimed at improving men’s health access and education across Australia.

Macquarie Group reports solid 3Q26 results with robust profit growth across divisions and a strong capital surplus, underpinned by strategic technology investments and regulatory compliance.

Macquarie Group has reported a solid third quarter for FY26, with significant profit gains in asset management and capital divisions, alongside steady growth in banking services. The group maintains a strong capital buffer, positioning itself well despite a cautious economic outlook.

Cannindah Resources has successfully raised over $11 million through the first tranche of its share placement, with the second tranche awaiting shareholder approval in March 2026.

DGR Global has been flagged by ASX for breaching Listing Rule 10.1 after advancing $500,000 without prior shareholder approval. The company is now preparing to seek retroactive approval and address further funding tranches.

Altamin Limited has obtained a retrospective Environmental Impact Assessment approval for its Gorno Project in Italy, strengthening its regulatory footing and supporting strategic options for development.

Iris Cairns Property Trust has confirmed new funding arrangements and plans to extend its takeover offer period for Reef Casino Trust, navigating regulatory hurdles and reassuring investors of its financial backing.

Imricor Medical Systems has taken a significant step toward US market entry by submitting its Advantage-MR EP Recorder/Stimulator system for FDA 510(k) clearance, aiming to enhance MRI-guided cardiac procedures.

Epsilon Healthcare’s subsidiary, Epsilon Pharma, has signed a three-year manufacturing agreement with New Zealand’s Puro to supply medicinal cannabis products to the UK and Europe, marking a significant step in its international expansion.